منابع مشابه
Mefloquine: the benefits outweigh the risks.
Introduction extensive and mefloquine is not detectable in the CSF. The drug is very slowly eliminated, mainly as a carboxylic acid metabolite, with a half-time of about 1 Falciparum malaria remains one of the world’s biggest killers, accounting for about 2.1 million deaths in 1995— month. It is excreted in breast milk [2]. Mefloquine is effective against many isolates of about 4% of all global...
متن کاملCorrespondence (letter to the editor): Benefits outweigh risks.
An ecological study for Spain illustrates this. The two factors used for vitamin D were nonmelanoma skin cancer (NMSC) mortality rate and latitude, for 48 provinces. NMSC was inversely correlated and/or latitude directly correlated with mortality rates for 15 types of cancer after adjustment for lung cancer mortality rates, included to account for the effect of smoking (3). Death rates were muc...
متن کاملAntidepressant Pharmacotherapy – Do the Benefits Outweigh the Risks?
Major depressive disorder (MDD) is a debilitating and often recurrent psychiatric illness that impacts the lives of millions. Approximately 20 percent of individuals will experience at least one depressive episode during their lives, and the high rates of chronic morbidity (depressive episodes typically last for several months) and mortality (owing to suicide) attributed to this disorder consti...
متن کاملDo risks outweigh benefits in thrombolysis for stroke?
1School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia; 2Emergency Department, Royal Perth Hospital, Perth, WA 6847, Australia; 3Emergency Department, Armadale Health Service, Armadale, WA 6992, Australia; 4School of Medicine and Pharmacology, University of Western Australia; 5Department of Neurology, Sir Charles Gairdner Hospital, Nedlands, Pert...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Deutsches Aerzteblatt Online
سال: 2011
ISSN: 1866-0452
DOI: 10.3238/arztebl.2011.0321a